• About
  • What is VICH
  • Role of VICH
  • VICH Structure
  • VICH Process
  • What is the VICH Outreach Forum
• Guidelines
  • General
  • Biologicals
  • Pharmaceuticals
  • Pharmacovigilance
• Activities
  • Dates of next meetings
  • Dates of next Public conference
  • Public consultations
• Library
  • Press releases
  • VICH Statements
  • VICH Steering Committee Minutes
  • VICH Outreach Forum minutes
  • Concept Papers
  • Procedural Guidance
  • Organisational documents (Priorities, Strategy and charter)
  • Conference documents archive
  • Other Documents
• Training
  • General training material
  • Module 1 - General Topics
  • Module 2 - Quality
  • Module 3 - Efficacy
  • Module 4 - Safety
  • Module 5 - Biologicals
  • Module 6 - Pharmacovigilance
• Contact

Members login

Remember me next time

I agree to the privacy policy

• 
• 
• 

Guidelines

Comments at Step 4

• VICH GL18(R2) - Comments at Step 4
  (Quality - Impurities)
• VICH GL59 - Comments at Step 4
  (Biologicals - LABST Veterinary Vaccines)
• VICH GL56 - Comments at Step 4
  (MRK - Honey)
• VICH GL54 - Comments at Step 4
  (Safety)
• VICH GL53 - Comments at Step 4
  (EFF)
• VICH GL52 - Comments at Step 4
  (Bioequivalence)
• VICH GL51 - Comments at Step 4
  (Pharmaceuticals - Quality: Stability Data)
• VICH GL50 - Comments at Step 4
  (Biologicals: TABST)